About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Phoenix | 100 Studies

Clinical Trials EpilepsyPhoenix

Epilepsy Clinical Trials in Phoenix

Find 100 clinical trials for epilepsy near Phoenix, Arizona. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 100 trials

CompletedEvaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial SeizuresThe purpose of this study was to evaluate the safety and tolerability of perampanel (up to 12 mg/day) given as adjunctive treatment in subjects with refractory partial seizures…NCT00735397·Birmingham, Alabama and 238 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Not yet recruitingCOMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"The goal of this clinical trial is to find out whether two existing medications-anakinra and tocilizumab-can effectively treat a rare and life-threatening brain condition called…NCT07281027·Phoenix, Arizona and 32 others

CompletedDouble-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresThis study will evaluate the efficacy and safety of Brivaracetam to support the submission file in the indication of adjunctive treatment in adolescents and adults with partial…NCT00464269·Phoenix, Arizona and 68 others

CompletedSafety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset SeizuresThe purpose of the trial is to evaluate the safety of intravenous (iv) lacosamide delivered in a single dose followed by 6.5 days of oral lacosamide treatment in subjects with…NCT00655551·Phoenix, Arizona and 6 others

TerminatedAn Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.This study will assess long-term safety and tolerability of repeat dose diazepam nasal spray in adolescents and adults with cluster seizures, with a focus on potential local…NCT02316847·Phoenix, Arizona and 32 others

CompletedOpen-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyThe purpose is to assess the safety of Lacosamide in subjects with uncontrolled Primary Generalized Tonic-Clonic (PGTC) seizures with Idiopathic Generalized Epilepsy.NCT01118949·Alabaster, Alabama and 24 others

CompletedStudy to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset SeizuresThe purpose of this study is to allow eligible subjects from the parent study, SP925 \[NCT00655551\] to continue lacosamide and to obtain additional long-term safety dataNCT00655486·Phoenix, Arizona and 6 others

RecruitingStudy of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))This clinical trial is designed to test whether a single image-guided intracerebral administration of inhibitory nerve cells, called interneurons (NRTX-1001), into subjects with…NCT05135091·Birmingham, Alabama and 34 others

TerminatedStudy to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersThe purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.NCT01390220·Phoenix, Arizona and 89 others

CompletedA Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset SeizuresThe study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3…NCT00465517·Birmingham, Alabama and 26 others

RecruitingA Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as…NCT05667142·Mobile, Alabama and 137 others

CompletedClobazam in Patients With Lennox-Gastaut SyndromeThe purpose of this study is to evaluate the safety and efficacy of clobazam as adjunctive therapy in the treatment of seizures which lead to drop attacks (drop seizures) in…NCT00518713·Huntsville, Alabama and 52 others

CompletedEfficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial SeizuresThe purpose of this study is to determine whether Eslicarbazepine acetate (BIA 2-093) is an effective adjunct therapy in the treatment of refractory partial seizuresNCT00988429·Mobile, Alabama and 161 others

RecruitingEpilepsy Learning Healthcare System (ELHS)The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy.NCT06265103·Phoenix, Arizona and 12 others

CompletedRufinamide Given as Adjunctive Therapy in Participants With Refractory Partial SeizuresTo evaluate the effect of rufinamide on total partial seizure frequency in adolescent and adult participants (12 to 80 years, inclusive) with refractory partial onset seizures…NCT00334958·Mobile, Alabama and 76 others

CompletedExtension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial SeizuresThis study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients…NCT00596466·Phoenix, Arizona and 43 others

CompletedA Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresThe X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101…NCT05614063·Mobile, Alabama and 124 others

CompletedSafety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset SeizuresThe purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of multiple doses of pregabalin in pediatric patients with partial onset seizures that are…NCT00437281·Mobile, Alabama and 17 others

CompletedOpen-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind TrialThe purpose of this study is to evaluate the safety and tolerability of long-term therapy with retigabine administered as adjunctive therapy in adult epilepsy patients with…NCT00310375·Birmingham, Alabama and 50 others

CompletedTo Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.NCT00141336·Phoenix, Arizona and 102 others

PreviousPage 5 of 5

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia